Literature DB >> 16842079

The blood-brain barrier in neuroAIDS.

Wiliam A Banks1, Nuran Ercal, Tulin Otamis Price.   

Abstract

Nearly every aspect of blood-brain barrier (BBB) function is involved in or affected by HIV-1. The disruption of the BBB tends to be minimal and is not likely the mechanism by which infected immune cells and virus enter the brain. Instead, immune cells, virus and viral proteins likely activate brain endothelial cells and enable their own passage across the BBB by way of highly regulated processes such as diapedesis and adsorptive endocytosis. Viral proteins and cytokines can enter the CNS from the blood and provide a mechanism by which HIV-1 can affect CNS function independent of viral transport. Brain endothelial cells can also secrete neuroimmunoactive substances when stimulated by HIV-1, gp120, and Tat. Efflux systems such as p-glycoprotein transport anti-virals in the brain-to-blood direction, thus hampering effective accumulation of drug by the CNS. Overall, the BBB plays a major role in establishing and maintaining virus within the CNS and neuroAIDS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842079     DOI: 10.2174/157016206777709447

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  53 in total

1.  Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult.

Authors:  Abraham Al Ahmad; Carole Bürgi Taboada; Max Gassmann; Omolara O Ogunshola
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-08       Impact factor: 6.200

2.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 3.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

4.  N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells.

Authors:  Xinsheng Zhang; Atrayee Banerjee; William A Banks; Nuran Ercal
Journal:  Brain Res       Date:  2009-04-15       Impact factor: 3.252

5.  HIV-1-induced alterations of claudin-5 expression at the blood-brain barrier level.

Authors:  Ibolya E András; Michal Toborek
Journal:  Methods Mol Biol       Date:  2011

6.  Disruption of the integrity and function of brain microvascular endothelial cells in culture by exposure to diesel engine exhaust particles.

Authors:  Shakila Tobwala; Xinsheng Zhang; Youyou Zheng; Hsiu-Jen Wang; William A Banks; Nuran Ercal
Journal:  Toxicol Lett       Date:  2013-03-28       Impact factor: 4.372

7.  Novel expression of PINCH in the central nervous system and its potential as a biomarker for human immunodeficiency virus-associated neurodegeneration.

Authors:  Ann Rearden; Rosemary Hurford; Nhan Luu; Emily Kieu; Melissa Sandoval; Georgina Perez-Liz; Luis Del Valle; Henry Powell; T Dianne Langford
Journal:  J Neurosci Res       Date:  2008-08-15       Impact factor: 4.164

8.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

9.  Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling.

Authors:  Yu Zhong; Eric J Smart; Babette Weksler; Pierre-Olivier Couraud; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

Review 10.  Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.

Authors:  Gabriel Gras; Marcus Kaul
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.